Test Background Vigabatrin has become widely used as an anticonvulsant with particular benefits in controlling partial seizures and those refractory to other therapies.
Clinical Indications Assessment of patient compliance
Assessment of suspected toxicity
Reference Range See report
Sample Required Serum (red top) or heparin (green top).
Sample Volume 2 mL pre-dose trough or 5 hours post-dose sample
Turnaround Time Up to 6 weeks
Notes Not currently performed in house; this is a referred test.
There are a few side effects reported with vigabatrin (drowsiness, dizziness and ataxia), which seem to be more related to dose than to plasma concentration.